Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2020 (Donepezil) in Dementia With Lewy Bodies
NCT01278407Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of donepezil in dementia with Lewy bodies (DLB), sponsored by Eisai Co., Ltd.. Started Feb 2011; status: completed.
02
Drugs
donepezil
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT01278407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278407.